Omnipaque



Indications and Reactions:

Role Indications Reactions
Primary
Diagnostic Procedure 50.0%
Product Used For Unknown Indication 29.0%
Abdominal Pain 3.1%
Pain Management 2.6%
Lung Neoplasm Malignant 2.1%
Hypertension 1.6%
Chest Pain 1.2%
Back Pain 1.0%
Abdominal Pain Lower 0.9%
Abdominal Pain Upper 0.9%
Computerised Tomogram 0.9%
Malignant Melanoma 0.9%
Non-alcoholic Steatohepatitis 0.9%
Pulmonary Embolism 0.9%
Fluid Replacement 0.7%
Headache 0.7%
Osteoporosis 0.7%
Routine Health Maintenance 0.7%
Breast Cancer 0.6%
Cancer Pain 0.6%
Urticaria 19.7%
Vomiting 13.6%
Meningitis Fungal 8.3%
No Adverse Event 7.9%
Rash 5.3%
Pruritus 4.8%
Pyrexia 4.8%
Renal Failure Acute 3.9%
Throat Irritation 3.5%
Throat Tightness 3.5%
Extravasation 3.1%
Tremor 3.1%
Erythema 2.6%
Loss Of Consciousness 2.6%
Rash Maculo-papular 2.6%
Anaphylactoid Shock 2.2%
Oxygen Saturation Decreased 2.2%
Shock 2.2%
Sneezing 2.2%
Anaphylactic Reaction 1.8%
Secondary
Diagnostic Procedure 46.7%
Product Used For Unknown Indication 33.1%
Abdominal Pain 2.5%
Pain Management 2.3%
Hypertension 1.6%
Lung Neoplasm Malignant 1.6%
Chest Pain 1.4%
Abdominal Pain Upper 1.1%
Routine Health Maintenance 1.1%
Percutaneous Coronary Intervention 1.0%
Dyspnoea 0.9%
Malignant Melanoma 0.9%
Acute Myocardial Infarction 0.8%
Computerised Tomogram 0.8%
Headache 0.8%
Non-alcoholic Steatohepatitis 0.8%
Nuclear Magnetic Resonance Imaging Abdominal 0.8%
Back Pain 0.6%
Breast Cancer 0.6%
Fluid Replacement 0.6%
Urticaria 19.5%
Vomiting 10.4%
Meningitis Fungal 8.6%
No Adverse Event 7.2%
Pruritus 5.4%
Rash 4.5%
Throat Irritation 4.5%
Tremor 4.5%
Drug Reaction With Eosinophilia And Systemic Symptoms 4.1%
Rash Maculo-papular 4.1%
Blood Creatinine Increased 3.2%
Pyrexia 3.2%
Throat Tightness 3.2%
Erythema 2.7%
Extravasation 2.7%
Loss Of Consciousness 2.7%
Renal Failure Acute 2.7%
Anaphylactoid Shock 2.3%
Oxygen Saturation Decreased 2.3%
Renal Tubular Necrosis 2.3%
Concomitant
Low Back Pain 18.9%
Therapeutic Embolisation 17.0%
Acute Lymphocytic Leukaemia 11.3%
Prophylaxis 9.4%
Pain 4.7%
Product Used For Unknown Indication 4.7%
Osteoporosis 3.8%
Anaesthesia 2.8%
Chronic Hepatitis C 2.8%
Coronary Artery Bypass 2.8%
Head And Neck Cancer 2.8%
Insomnia 2.8%
Lumbar Radiculopathy 2.8%
Back Pain 1.9%
Colitis Ulcerative 1.9%
Computerised Tomogram 1.9%
Constipation Prophylaxis 1.9%
Gastritis 1.9%
Hepatic Cirrhosis 1.9%
Hepatic Neoplasm Malignant 1.9%
Meningitis 31.0%
Hospitalisation 11.9%
Vaginal Haemorrhage 7.1%
Cholecystitis Acute 4.8%
Nuclear Magnetic Resonance Imaging 4.8%
Renal Failure Acute 4.8%
Unevaluable Event 4.8%
Bradycardia 2.4%
Cerebrovascular Accident 2.4%
Dehydration 2.4%
Dyspnoea 2.4%
Enterocolitis 2.4%
Headache 2.4%
International Normalised Ratio Increased 2.4%
Malaise 2.4%
Neck Pain 2.4%
Oedema 2.4%
Photophobia 2.4%
Pneumonia 2.4%
Pyrexia 2.4%
Interacting
Drug Use For Unknown Indication 100.0%
Renal Tubular Necrosis 100.0%